Clinical trials
Recruiting Phase 3 Pulmonary Arterial Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AOP Orphan Pharmaceuticals AG | 1 |
| Actelion | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Gossamer Bio USA, Inc. | 1 |
| Inhibikase Therapeutics | 1 |
| Insmed Incorporated | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| University of Arizona | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 9 |
| Cardiovascular Diseases | 2 |
| Acute Lung Injury | 1 |
| Hypertension, Pulmonary | 1 |
| Lung Diseases, Interstitial | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.